Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Cancer Research

• Publication date

  1983-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 6616464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.

  1982cited by this paper
• Optimal Scheduling of Methotrexate and 5-Fluorouracil in Human Breast Cancer

  1982cited by this paper
• Biochemical alterations during unperturbed suspension growth of L1210 cells.

  1981cited by this paper
• Treatment of primary breast cancer with chemotherapy and tamoxifen.

  1981cited by this paper
• Criteria for analyzing interactions between biologically active agents.

  1981influential reference
• Differential interaction of antiestrogens with cytosol estrogen receptors.

  1981cited by this paper
• Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.

  1981cited by this paper
• Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.

  1981cited by this paper
• The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.

  1981cited by this paper
• CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.

  1980cited by this paper
• Regulation of ribosomal ribonucleic acid levels in growing, 3H-arrested, and crisis-phase WI-38 human diploid fibroblasts.

  1980cited by this paper
• Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines.

  1980cited by this paper
• Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function.

  1980cited by this paper
• Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.

  1980influential reference
• I. THEORETICAL OUTLINE OF A NEW METHOD TO ANALYZE TIME SEQUENCES OF DNA HISTOGRAMS

  1980influential reference
• G1 and S phase mammalian cells synthesize histones at equivalent rates.

  1980cited by this paper
• Studies on mechanisms of estrogen and antiestrogen action in human breast cancer.

  1980cited by this paper
• Establishment and characterization of a cell line of human breast carcinoma origin.

  1979cited by this paper
• Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.

  1979influential reference
• Antihormone treatment of stage IV breast cancer

  1979cited by this paper
• Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.

  1978influential reference
• Medical treatment for advanced breast cancer.

  1978cited by this paper
• Steroid receptor analyses of nine human breast cancer cell lines.

  1978cited by this paper
• Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.

  1978cited by this paper
• Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

  1978cited by this paper
• Medical treatment for advanced breast cancer.

  1978cited by this paper
• Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen.

  1978cited by this paper
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Antiestrogen action: differential nuclear retention and extractability of the estrogen receptor.

  1976cited by this paper
• The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Interactions of antiestrogens with human breast cancer in long-term tissue culture.

  1976cited by this paper
• Proliferation-dependent cytotoxicity of anticancer agents: a review.

  1975influential reference
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper
• The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.

  1965cited by this paper
• Combination Chemotherapy with Actinomycin D and Ribonuclease : an Example of Complementary Inhibition

  1964cited by this paper
• November

  1890cited by this paper

• Combination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial

  2024cites this paper
• In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells.

  2020cites this paper
• Challenges and Potential for Ovarian Preservation with SERMs1

  2015cites this paper
• Scientific concepts and applications of integrated discrete multiple organ co-culture technology

  2015cites this paper
• Definition of metabolism-dependent xenobiotic toxicity with co-cultures of human hepatocytes and mouse 3T3 fibroblasts in the novel integrated discrete multiple organ co-culture (IdMOC) experimental system: results with model toxicants aflatoxin B1, cyclophosphamide and tamoxifen.

  2012cites this paper
• Signalisation par les récepteurs des œstrogènes : mécanismes de reconnaissance de l’ADN et nouvelles approches pharmacologiques d’inhibition

  2012cites this paper
• Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

  2011cites this paper
• Roles and Mechanisms of Estrogen and Estrogen Receptors in Breast Cancer Resistant to Chemotherapy

  2011cites this paper
• The role of estrogen and estrogen receptors in chemoresistance.

  2011cites this paper
• Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer

  2009cites this paper
• In vitro sensitivity testing of human breast cancer cells to hormones and chemotherapeutic agents

  2008cites this paper
• Effect of Tamoxifen on the Multidrug-resistant Phenotype in Human Breast Cancer Cells : Isobologram , Drug Accumulation , and Mr 170 , 000 Glycoprotein ( gpl 70 ) Binding Studies 1

  2007cites this paper
• Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells

  2007cites this paper
• Effects of Estrogen and Tamoxifen on the Regulation of Dihydrofolate ReducÃ-aseGene Expression in a Human Breast Cancer Cell Line

  2006cites this paper
• Effects of experimental chemoendocrine therapy with a combination of a pure antiestrogen and 5-fluorouracil on human breast cancer cells implanted in nude mice

  2006cites this paper
• Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates.

  2004cites this paper
• Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study.

  2004cites this paper
• Identification of structural components associated with cytostatic activity in MCF-7 but not in MDA-MB-231 cells.

  2003cites this paper
• Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer.

  2000cites this paper
• Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer.

  2000cites this paper
• Influences of social housing conditions on chemotherapeutic efficacy : tumor, host and temporal factors

  2000cites this paper
• Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.

  1999cites this paper
• [Colon cancer and vitamin D--in vivo growth inhibition of colon cancer by a fluorinated analogue of 1,25-(OH)2D3, DD-003].

  1996cites this paper
• Aromatase activity and CYP19 gene expression in breast cancers.

  1996cites this paper
• Anti-Growth Factor Activity of Antiestrogens in Human Breast Cancer Cells: A Review

  1995cites this paper
• Apoptosis in Hormone-Dependent Cancers

  1995cites this paper
• Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies.

  1994cites this paper
• Steroids, growth factors, and cell cycle controls in breast cancer.

  1991cites this paper
• Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.

  1991cites this paper
• Interleukin-1 alpha differentially synchronizes estrogen-dependent and estrogen-independent human breast cancer cells in the G0/G1 phase of the cell cycle.

  1991cites this paper
• Endocrine pharmacology of antiestrogens as antitumor agents.

  1990cites this paper
• Manipulation of the growth rate of human breast cancer cells by antiandrogen followed by chemotherapy.

  1990cites this paper
• The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro

  1990cites this paper
• Relationship between tumour aromatase activity, tumour characteristics and response to therapy.

  1990cites this paper
• The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study.

  1989cites this paper
• In vitro evaluation of 6-thioguanine and alpha-interferon as a therapeutic combination in HL-60 and natural killer cells.

  1989cites this paper
• Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens.

  1989cites this paper
• Evidence of a new metabolic pathway of 5-fluorouracil in Escherichia coli from in vivo 19F-NMR spectroscopy.

  1989cites this paper
• In Vitro Predictive Sensitivity Testing in the Therapeutic Assessment of Breast Cancer

  1989cites this paper
• What is synergy?

  1989cites this paper
• The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer.

  1989cites this paper
• Studies relating to the breast, its tumours and fluids

  1988cites this paper
• Growth inhibitory effect of LH-RH analogs on human breast cancer cells.

  1988cites this paper
• Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continuous culture.

  1988cites this paper
• The metabolic basis for combination chemotherapy.

  1988cites this paper
• Effects of estrogens and antiestrogens on cell proliferation: implications for the treatment of breast cancer.

  1988cites this paper
• Lethal efficacy of doxorubicin on human medullary thyroid carcinoma cells in vitro.

  1988cites this paper
• Effects of hormonal modulation on cytotoxicity of chemotherapeutic agents in mouse mammary tumor cell cultures.

  1988cites this paper
• Effects of Estrogens and Antiestrogens on Cell Proliferation

  1988cites this paper
• Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells.

  1987cites this paper
• Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.

  1987cites this paper
• Enhancement of hormonal synchronization and 5-fluorouracil cytotoxicity in breast cancer cells by low concentration of thymidine.

  1987cites this paper
• Chemoendocrine therapy with prolonged estrogen priming in advanced breast cancer: endocrine pharmacokinetics and toxicity.

  1987cites this paper
• Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells.

  1987cites this paper
• Advances in rational combination chemotherapy.

  1986cites this paper
• Growth inhibition of laryngeal UM-SCC cell lines by tamoxifen. Comparison with effects on the MCF-7 breast cancer cell line.

  1986cites this paper
• Direct Effects of LHRH and Agonists on Human Breast Cancer Cells

  1986cites this paper
• Predictive models for potentiation of cell killing by combined exposure in vitro to photon radiation and BCNU

  1986cites this paper
• Modulation of 5-Fluorouracil Cytotoxicity by Intracellular Pools of 5-Phosphoribosyl-1-Pyrophosphate (PRPP)

  1986cites this paper
• Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.

  1986cites this paper
• Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

  1985cites this paper
• The expected effect of a combination of agents: the general solution.

  1985cites this paper
• Anatagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro

  1985cites this paper
• Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.

  1985cites this paper
• Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions.

  1985cites this paper
• Antagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro.

  1985cites this paper
• Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line.

  1985cites this paper
• Tamoxifen - 5-fluorouracil synergy in human breast cancer cell lines : correlating in vitro synergy with the current estrogen receptor model

  1985influential citation
• The design of rational combination chemotherapy for cancer.

  1984cites this paper
• Antiproliferative actions of tamoxifen to human ovarian carcinomas in vitro.

  1984cites this paper
• Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA.

  1983cites this paper
• Medical Staff Conference The Design of Rational Combination Chemotherapy for Cancer

  year unknowncites this paper